Switching therapies in MS: what are the options?
From the Department of Neurology and the Multiple Sclerosis Center, the Hospital of the University of Pennsylvania, Philadelphia.
Clyde E
CE
Markowitz
D006801:Humans; D007155:Immunologic Factors / Q000009:adverse effects / Q000627:therapeutic use*; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D055118:Medication Adherence; D009103:Multiple Sclerosis / Q000175:diagnosis / Q000188:drug therapy*; D016896:Treatment Outcome
D007155:Immunologic Factors; D007166:Immunosuppressive Agents